Response and outcomes of patients with <i>IDH1/2-</i> mutated accelerated/blast-phase myeloproliferative neoplasms.

ABSTRACT:

SUBMITTER: Goldberg LA 

PROVIDER: S-EPMC12423677 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature